Mr. Lau Ka Ho (劉家豪), was appointed as an executive director, chief financial officer, company secretary, member of nomination committee and member of executive committee of the Company on 24 May 2019. He was also appointed as the member of remuneration committee and chairman of investment and credit committee of the Company on 31 December 2019 and 8 January 2021 respectively. Mr. Lau had been re-designated from the position of Chief Financial Officer to the Chief Executive Officer and resigned as the company secretary on 31 December 2019. He had also been re-designated from the member of executive committee to the chairman of executive committee on 30 June 2021. Mr. Lau ceased to be the chairman and a member of the executive committee and the investment and credit committee following the dissolution of such committees with effect from 28 August 2025. He is currently the director of certain subsidiaries of the Group. Mr. Lau holds a Master’s degree in business administration from The University of Iowa and a Master’s degree in corporate governance from Hong Kong Metropolitan University. Mr. Lau is a fellow member of both The Hong Kong Chartered Governance Institute and The Chartered Governance Institute. He is also a member of The Hong Kong Institute of Directors and holds a Diploma in Company Direction.
He has more than 20 years of experience in corporate management, corporate finance and corporate secretarial areas.
Mr. Lau was an independent non-executive director of International Entertainment Corporation (a company listed on the main board of Stock Exchange; stock code: 1009) from 1 June 2020 to 25 September 2025.
He was also appointed as an executive director of Hong Kong Zcloud Technology Construction Limited (a company listed on the main board of Stock Exchange; stock code: 9900; formerly known as Gain Plus Holdings Limited) on 25 February 2021 and was the company secretary from 3 September 2021 to 12 February 2025.
Mr. Yu Ching Him (余正謙), was appointed as an executive director and chief financial officer of the Company on 8 September 2025. He has been the chief financial officer of certain subsidiaries of the Group since 11 June 2024 and is currently a director of certain subsidiaries of the Group.
Mr. Yu graduated from The Hong Kong Polytechnic University with a Bachelor of Arts in Accountancy. Before joining the Company, Mr. Yu had worked in international accounting firm and as financial management positions in listed companies and private companies. Mr. Yu is a member of the Hong Kong Institute of Certified Public Accountants and has over 20 years of experience in accounting and auditing fields.
Ms. Chan Sze Man (陳詩敏), was appointed as an independent non-executive director of the Company on 20 September 2016. She is also the chairman of each of the Audit Committee and the Nomination Committee and member of Remuneration Committee of the Company. Ms. Chan received a Bachelor’s Degree in Business Administration (majoring in Accountancy) from The Hong Kong University of Science and Technology. Ms. Chan is a member of the Hong Kong Institute of Certified Public Accountants and has over 20 years of experience in accounting and auditing for Hong Kong listed companies and private companies. Ms. Chan is currently a non-executive director of Tongda Group Holdings Limited (a company listed on the main board of the Stock Exchange; stock code: 698) and an independent non-executive director of Chi Kan Holdings Limited (a company listed on the main board of Stock Exchange; stock code: 9913) and Weiye Holdings Limited (a company listed on the main board of Stock Exchange; stock code: 1570). Ms. Chan has been appointed as an independent non-executive director of China Wantian Holdings Limited (a company listed on the main board of Stock Exchange; stock code: 1854) since 6 November 2025, an independent non-executive director of Shanghai XNG Holdings Limited (a company listed on the main board of Stock Exchange; stock code: 3666) since 23 December 2025 and an independent director of Green Circle Decarbonize Technology Limited (a company listed on NYSE American Exchange in United States of America; stock code: GCDT) since January 2026.
Mr. Wong Sai Hung (王世雄), was appointed as an independent non-executive director of the Company on 29 December 2023. He is also the chairman of the Remuneration Committee and member of the Audit Committee of the Company. He obtained a Bachelor of Commerce degree from the University of Toronto and a Bachelor of Laws degree from the City University of Hong Kong in 2006. He also obtained the Postgraduate Certificate in Laws from the University of Hong Kong in 2008. He was admitted as a solicitor of the High Court of Hong Kong in 2010. He is a member of The Hong Kong Institute of Certified Public Accountants, a chartered financial analyst of The CFA Institute and a financial risk manager of The Global Association of Risk Professionals. Mr. Wong has been appointed as an independent non-executive director of Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (a company listed on the main board of Stock Exchange; stock code: 3378) since 23 December 2025.
Mr. Wong Ming Hung (黃明雄), was appointed as an independent non-executive director of the Company on 14 August 2026. Mr. Wong holds a Master of Science in Finance from the City University of Hong Kong and is a member of the Hong Kong Institute of Certified Public Accountants. Mr. Wong has over 20 years of professional experience in taxation, auditing, financial management and business development, including approximately 14 years with a renewable energy company listed in Hong Kong. He also worked in internal audit and risk management at a property company listed in Hong Kong for about 2 years. Prior to that, he was engaged in internal audit at a manufacturing group listed in Hong Kong.